50-112-2560

CD178 (Fas Ligand) Monoclonal Antibody (MFL3), Biotin, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 50-112-2560-Each-of-1 In Stock ₹ 16,821.00

50-112-2560 - Each of 1

₹ 16,821.00

In Stock

Quantity

1

Base Price: ₹ 16,821.00

GST (18%): ₹ 3,027.78

Total Price: ₹ 19,848.78

Antigen

CD178 (Fas Ligand)

Classification

Monoclonal

Concentration

0.5 mg/mL

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Accession No.

P41047

Gene Symbols

Fasl

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

14103

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

MFL3

Conjugate

Biotin

Gene

Fasl

Gene Alias

ADAM10-processed FasL form; ALPS1B; APL; Apoptosis (APO 1) antigen ligand 1; apoptosis (APO-1) antigen ligand 1; Apoptosis (APO-1) antigen ligand 1 (Fas antigen ligand); apoptosis antigen ligand; APT1LG1; APTL; CD178; CD178 antigen; CD95 ligand; CD95 ligand protein;Generalized lymphoproliferative disease (Gld); Cd95l; CD95-L; CD95L protein; fas antigen ligand; Fas ligand; Fas ligand (TNF superfamily, member 6); Fasl; Fas-L; FasL ICD; FasL intracellular domain; Faslg; Fas-LG; generalized lymphoproliferative disease; gld; mutant tumor necrosis factor family member 6; Receptor-binding FasL ectodomain; sFasL; Soluble Fas ligand; soluble form; SPA; SPPL2A-processed FasL form; TNFL; Tnfsf6; TNLG1A; Tumor necrosis factor (ligand) superfamily member 6; Tumor necrosis factor (ligand) superfamily member 6 (apoptosis (APO-1) antigen ligand 1) (Fas antigen ligand); Tumor necrosis factor (ligand) superfamily, member 6 (apoptosis (APO-1) antigen ligand 1) (Fas antigen ligand); Tumor necrosis factor

Host Species

Armenian Hamster

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Mouse

Product Type

Antibody

Isotype

IgG

Related Products

Img

Invitrogen

46-095-942

--

Img

Invitrogen

50-110-98

--

Img

Invitrogen

50-112-35

--

Img

Invitrogen

46590642

--

Img

Invitrogen

50-107-42

--

Img

Invitrogen

48-154-182

--

Img

Invitrogen

50-112-3773

--

Img

Invitrogen

50-106-18

--

Description

  • Description: The MFL3 monoclonal antibody reacts with mouse Fas (CD95) Ligand, a 40 kDa type II transmembrane glycoprotein
  • FasL is a member of the TNF family and is expressed by mouse activated T cells
  • The interaction of FasL with its receptor CD95 induces Fas-mediated killing
  • It has been reported that the human FasL antigen is cleaved from the surface by matrix metalloproteinases (MMPs), resulting in a 26 kDa soluble form
  • The degree of sensitivity for the mouse antigen to MMPs has not been reported
  • Applications Reported: The MFL3 antibody has been reported for use in flow cytometric analysis
  • Applications Tested: The MFL3 antibody has been tested by flow cytometric analysis of mouse FasL transfected cells and activated T cells
  • This can be used at less than or equal to 0.25 μg per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest
  • Filtration: 0.2 μm post-manufacturing filtered
  • CD178 (Fas ligand, FasL) is a type-II-membrane protein, whose N-terminus is in the cytoplasm and its C-terminal region extends into the extracellular space
  • Its receptor, FasR, is a cell-surface-type-I-membrane protein and a member of the tumor necrosis factor (TNF) and nerve growth factor (NGF) receptor family
  • As a member of the TNF-cytokine family CD178 induces apoptosis when interacting with FasR
  • CD178 may exist as either membrane bound (45 kD) or soluble forms (26 kD)
  • The soluble protein can be released from cells upon cleavage by metalloproteinases
  • Binding of CD178 to Fas leads to oligomerization of the receptor and triggers apoptotic cell death through the interaction of other proteins
  • CD178 is predominantly expressed in activated T-lymphocytes and natural killer (NK) cells also it is expressed in the tissues of immune-privilege sites such as testis and eye
  • CD178 expression is also reported in various tissues as thymus, liver, ovary, lung, heart and kidney
  • It is assumed that induction of apoptosis through CD178 is predominantly involved in anti-viral immune responses
  • CD178 is a cell surface molecule belonging to the tumor necrosis factor family, binds to its receptor Fas, thus inducing apoptosis
  • Various cells express FAS, where CD178 is expressed predominantly on activated T cells
  • FAS and CD178 are involved in the down-regulation of immune reactions as well as T cell-mediated cytotoxicity
  • CD178 concentration has also been shown to be associated with atherosclerosis and inflammatory disease, in patients with hypertension
  • The Fas/ CD178 system has been shown to play a role in a number of human diseases, for example AIDS, hepatitis or cancer.